Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin.

http://www.ncbi.nlm.nih.gov/pubmed/22219281

Huntington's disease (HD) is caused by a polyglutamine expansion in the Huntingtin (Htt) protein. Proteolytic cleavage of Htt into toxic N-terminal fragments is believed to be a key aspect of pathogenesis. The best characterized putative cleavage event is at amino acid 586, hypothesized to be mediated by caspase 6. A corollary of the caspase 6 cleavage hypothesis is that the caspase 6 fragment should be a toxic fragment. To test this hypothesis, and further characterize the role of this fragment, we have generated transgenic mice expressing the N-terminal 586 aa of Htt with a polyglutamine repeat length of 82 (N586-82Q), under the control of the prion promoter. N586-82Q mice show a clear progressive rotarod deficit by 4 months of age, and are hyperactive starting at 5 months, later changing to hypoactivity before early mortality. MRI studies reveal widespread brain atrophy, and histologic studies demonstrate an abundance of Htt aggregates, mostly cytoplasmic, which are predominantly composed of the N586-82Q polypeptide. Smaller soluble N-terminal fragments appear to accumulate over time, peaking at 4 months, and are predominantly found in the nuclear fraction. This model appears to have a phenotype more severe than current full-length Htt models, but less severe than HD mouse models expressing shorter Htt fragments. These studies suggest that the caspase 6 fragment may be a transient intermediate, that fragment size is a factor contributing to the rate of disease progression, and that short soluble nuclear fragments may be most relevant to pathogenesis.

Pubmed ID: 22219281 RIS Download

Mesh terms: Animals | Atrophy | Caspase 6 | Disease Models, Animal | Humans | Huntington Disease | Mice | Mice, Inbred Strains | Mice, Transgenic | Nerve Degeneration | Nerve Tissue Proteins | Nuclear Proteins | Peptide Fragments | Trinucleotide Repeat Expansion

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: PHS HHS, Id: NINDS 16375
  • Agency: NINDS NIH HHS, Id: P50 NS016375
  • Agency: NINDS NIH HHS, Id: P50 NS016375-30
  • Agency: NINDS NIH HHS, Id: R01 NS086452
  • Agency: NIMH NIH HHS, Id: T32 MH015330
  • Agency: NIMH NIH HHS, Id: T32 MH015330-35
  • Agency: Intramural NIH HHS, Id:

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.